- Home
- MPU vs DXR Comparison
MPU vs DXR Comparison
Compare MPU & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- DXR
- Stock Information
- Founded
- MPU 1989
- DXR 1970
- Country
- MPU Singapore
- DXR United States
- Employees
- MPU N/A
- DXR N/A
- Industry
- MPU Transportation Services
- DXR Medical/Dental Instruments
- Sector
- MPU Consumer Discretionary
- DXR Health Care
- Exchange
- MPU Nasdaq
- DXR Nasdaq
- Market Cap
- MPU 35.5M
- DXR 36.4M
- IPO Year
- MPU 1998
- DXR N/A
- Fundamental
- Price
- MPU $1.63
- DXR $9.83
- Analyst Decision
- MPU
- DXR Strong Buy
- Analyst Count
- MPU 0
- DXR 1
- Target Price
- MPU N/A
- DXR $25.00
- AVG Volume (30 Days)
- MPU 673.0K
- DXR 6.1K
- Earning Date
- MPU 08-13-2025
- DXR 01-01-0001
- Dividend Yield
- MPU N/A
- DXR N/A
- EPS Growth
- MPU N/A
- DXR 86.16
- EPS
- MPU N/A
- DXR 0.11
- Revenue
- MPU $35,228,600.00
- DXR $119,714.00
- Revenue This Year
- MPU N/A
- DXR N/A
- Revenue Next Year
- MPU N/A
- DXR N/A
- P/E Ratio
- MPU N/A
- DXR $90.43
- Revenue Growth
- MPU 305.32
- DXR N/A
- 52 Week Low
- MPU $0.49
- DXR $6.55
- 52 Week High
- MPU $1.98
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- MPU 77.55
- DXR 65.32
- Support Level
- MPU $0.80
- DXR $9.02
- Resistance Level
- MPU $1.70
- DXR $9.03
- Average True Range (ATR)
- MPU 0.19
- DXR 0.54
- MACD
- MPU 0.08
- DXR 0.02
- Stochastic Oscillator
- MPU 89.22
- DXR 96.50
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.